$CBUS
Cibus, Inc. Stock $cbus

$cbus Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000095017021000951 Filed on August 05, 2021

Income Statement

Concept	2021 Q3	2021 Q2	2020 Q2
Revenue	$7.762M	$11.88M	$2.307M
YoY Change	48.1%	414.95%	465.44%
Cost Of Revenue	$8.281M	$11.53M	$5.321M
YoY Change	17.29%	116.63%	1656.11%
Gross Profit	-$519.0K	$353.0K	-$3.014M
YoY Change	-71.47%	-111.71%	-2970.48%
Gross Profit Margin	-6.69%	2.97%	-130.65%
Selling, General & Admin	$3.859M	$3.493M	$5.167M
YoY Change	-14.68%	-32.4%	-19.37%
% of Gross Profit		989.52%
Research & Development	$2.579M	$2.844M	$2.825M
YoY Change	17.01%	0.67%	3.18%
% of Gross Profit		805.67%
Depreciation & Amortization	$596.0K	$590.0K	$450.0K
YoY Change	26.81%	31.11%	28.57%
% of Gross Profit		167.14%
Operating Expenses	$6.438M	$6.337M	$8.034M
YoY Change	-10.97%	-21.12%	-16.29%
Operating Profit	-$6.957M	-$5.984M	-$11.05M
YoY Change	-23.13%	-45.84%	16.39%
Interest Expense	$356.0K	$359.0K	$371.0K
YoY Change	-3.52%	-3.23%	0.27%
% of Operating Profit
Other Income/Expense, Net	$6.000K	$6.000K	-$8.000K
YoY Change	-105.88%	-175.0%
Pretax Income	-$7.307M	-$4.807M	-$10.90M
YoY Change	-22.89%	-55.91%	15.94%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$7.307M	-$4.807M	-$10.90M
YoY Change	-22.89%	-55.91%	15.94%
Net Earnings / Revenue	-94.14%	-40.46%	-472.56%
Basic Earnings Per Share	-$0.20	-$0.13
Diluted Earnings Per Share	-$196.0K	-$0.13	-$329.9K
COMMON SHARES
Basic Shares Outstanding	37.27M	37.20M	33.04M
Diluted Shares Outstanding	37.28M	37.20M

Balance Sheet

Concept	2021 Q3	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.92M	$17.49M	$33.80M
YoY Change	-50.28%	-48.26%	-55.76%
Cash & Equivalents	$13.92M	$17.49M	$3.875M
Short-Term Investments	$0.00	$0.00	$29.90M
Other Short-Term Assets	$1.450M	$1.022M	$2.300M
YoY Change	-23.68%	-55.57%	21.05%
Inventory	$1.674M	$2.468M	$5.282M
Prepaid Expenses
Receivables	$206.0K	$3.994M	$2.411M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$17.25M	$24.97M	$43.80M
YoY Change	-54.96%	-42.98%	-44.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.48M	$22.00M	$22.70M
YoY Change	-5.81%	-3.09%	0.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$195.0K	$207.0K	$1.500M
YoY Change	-86.07%	-86.2%	-16.67%
Total Long-Term Assets	$22.27M	$22.80M	$24.20M
YoY Change	-7.98%	-5.77%	-0.41%
TOTAL ASSETS
Total Short-Term Assets	$17.25M	$24.97M	$43.80M
Total Long-Term Assets	$22.27M	$22.80M	$24.20M
Total Assets	$39.52M	$47.78M	$68.00M
YoY Change	-36.77%	-29.74%	-34.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.037M	$2.183M	$600.0K
YoY Change	-13.58%	263.83%	50.0%
Accrued Expenses	$1.139M	$2.326M	$3.300M
YoY Change	-80.69%	-29.52%	3.13%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$387.0K	$380.0K	$400.0K
YoY Change	-3.25%	-5.0%	33.33%
Total Short-Term Liabilities	$5.100M	$7.156M	$4.600M
YoY Change	-35.44%	55.57%	-8.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$1.518M
YoY Change	-100.0%	-100.0%	-91.7%
Other Long-Term Liabilities	$971.0K	$1.042M	$100.0K
YoY Change	871.0%	942.0%	-50.0%
Total Long-Term Liabilities	$971.0K	$1.042M	$1.518M
YoY Change	-95.05%	-31.36%	-91.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.100M	$7.156M	$4.600M
Total Long-Term Liabilities	$971.0K	$1.042M	$1.518M
Total Liabilities	$23.70M	$25.88M	$24.40M
YoY Change	-14.14%	6.07%	4.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$189.0M	-$181.7M	-$144.0M
YoY Change		26.18%
Common Stock	$205.9M	$204.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.83M	$21.90M	$43.55M
YoY Change
Total Liabilities & Shareholders Equity	$39.52M	$47.78M	$67.96M
YoY Change	-36.77%	-29.7%	-34.4%

Cashflow Statement

Concept	2021 Q3	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	-$7.307M	-$4.807M	-$10.90M
YoY Change	-22.89%	-55.91%	15.94%
Depreciation, Depletion And Amortization	$596.0K	$590.0K	$450.0K
YoY Change	26.81%	31.11%	28.57%
Cash From Operating Activities	-$3.405M	-$1.829M	-$13.42M
YoY Change	-36.24%	-86.37%	103.64%
INVESTING ACTIVITIES
Capital Expenditures	-$69.00K	-$37.00K	-$200.0K
YoY Change	-89.05%	-81.5%	-79.38%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$3.048M	$8.680M
YoY Change	-100.0%	-64.88%
Cash From Investing Activities	-$69.00K	$3.011M	$8.480M
YoY Change	-100.81%	-64.49%	-974.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-93.00K	-71.00K	1.440M
YoY Change	-177.5%	-104.93%	-726.09%
NET CHANGE
Cash From Operating Activities	-3.405M	-1.829M	-13.42M
Cash From Investing Activities	-69.00K	3.011M	8.480M
Cash From Financing Activities	-93.00K	-71.00K	1.440M
Net Change In Cash	-3.567M	1.111M	-3.500M
YoY Change	-208.42%	-131.74%	-55.07%
FREE CASH FLOW
Cash From Operating Activities	-$3.405M	-$1.829M	-$13.42M
Capital Expenditures	-$69.00K	-$37.00K	-$200.0K
Free Cash Flow	-$3.336M	-$1.792M	-$13.22M
YoY Change	-29.17%	-86.44%	135.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
	dei	Entity Central Index Key EntityCentralIndexKey	0001705843
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38161
	dei	Entity Registrant Name EntityRegistrantName	Calyxt, Inc.
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1967997
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2800 Mount Ridge Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Roseville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55113-1127
	dei	City Area Code CityAreaCode	651
	dei	Local Phone Number LocalPhoneNumber	683-2807
	dei	Security12b Title Security12bTitle	Common Stock (0.0001 par value)
	dei	Trading Symbol TradingSymbol	CLXT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37270998
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17489000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17299000
CY2021Q2	us-gaap	Short Term Investments ShortTermInvestments	0
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	11698000
CY2021Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	393000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	393000
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3994000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4887000
CY2021Q2	us-gaap	Inventory Net InventoryNet	2468000
CY2020Q4	us-gaap	Inventory Net InventoryNet	1383000
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	629000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3930000
CY2021Q2	us-gaap	Assets Current AssetsCurrent	24973000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	39590000
CY2021Q2	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	598000
CY2020Q4	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	597000
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21998000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22860000
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	207000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	280000
CY2021Q2	us-gaap	Assets Assets	47776000
CY2020Q4	us-gaap	Assets Assets	63327000
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2183000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	929000
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2326000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2891000
CY2021Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	2093000
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1950000
CY2021Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	128000
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	766000
CY2021Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	380000
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	364000
CY2021Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	46000
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	45000
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7156000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6945000
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	17682000
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	17876000
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1518000
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1042000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	113000
CY2021Q2	us-gaap	Liabilities Liabilities	25880000
CY2020Q4	us-gaap	Liabilities Liabilities	26452000
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	275000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	275000000
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37305625
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37205473
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37165196
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37065044
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	4000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	4000
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	204663000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	204807000
CY2021Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	100152
CY2020Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	100152
CY2021Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1043000
CY2020Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1043000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-181728000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-166893000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	21896000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	36875000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47776000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63327000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11880000
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2307000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16282000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4684000
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11527000
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5321000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18272000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9205000
CY2021Q2	us-gaap	Gross Profit GrossProfit	353000
CY2020Q2	us-gaap	Gross Profit GrossProfit	-3014000
	us-gaap	Gross Profit GrossProfit	-1990000
	us-gaap	Gross Profit GrossProfit	-4521000
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2844000
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2825000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5894000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5612000
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3478000
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5167000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7736000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11465000
CY2021Q2	clxt	Management Fees ManagementFees	15000
CY2020Q2	clxt	Management Fees ManagementFees	42000
	clxt	Management Fees ManagementFees	45000
	clxt	Management Fees ManagementFees	104000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	6337000
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	8034000
	us-gaap	Operating Expenses OperatingExpenses	13675000
	us-gaap	Operating Expenses OperatingExpenses	17181000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5984000
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11048000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15665000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21702000
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1528000
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1528000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-357000
CY2020Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	154000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-703000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-244000
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6000
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4807000
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10902000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14835000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21965000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-4807000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-10902000
	us-gaap	Net Income Loss NetIncomeLoss	-14835000
	us-gaap	Net Income Loss NetIncomeLoss	-21965000
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.33
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.40
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.67
CY2021Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37199349
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33039338
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37168018
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33013739
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5223327
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5140153
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5223327
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5140153
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	25605000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-4807000
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1079000
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	19000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	21896000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	52536000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-10902000
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1797000
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	122000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	43553000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	36875000
	us-gaap	Net Income Loss NetIncomeLoss	-14835000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-371000
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	227000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	21896000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	62508000
	us-gaap	Net Income Loss NetIncomeLoss	-21965000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3068000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-58000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	43553000
	us-gaap	Profit Loss ProfitLoss	-14835000
	us-gaap	Profit Loss ProfitLoss	-21965000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1528000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1180000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	904000
	us-gaap	Share Based Compensation ShareBasedCompensation	-371000
	us-gaap	Share Based Compensation ShareBasedCompensation	3068000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-893000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1289000
	clxt	Increase Decrease In Due To From Related Parties Current IncreaseDecreaseInDueToFromRelatedPartiesCurrent	-638000
	clxt	Increase Decrease In Due To From Related Parties Current IncreaseDecreaseInDueToFromRelatedPartiesCurrent	-598000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1085000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2688000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3301000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1118000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1254000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-505000
	clxt	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses	-555000
	clxt	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses	-546000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5308000
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	143000
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-888000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-992000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	26000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11249000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25651000
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-11698000
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	29942000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	307000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	525000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18289000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60038000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18480000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	11391000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30467000
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1518000
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	178000
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	130000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	227000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	49000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1388000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	191000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-54730000
CY2020Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	12165000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1634125
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18289000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5308000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2347663
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.15
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4621173
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.30
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	456959
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.71
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	61372
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.70
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	550110
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	10.57
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2412501
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.49
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4466650
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.89
CY2021Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19000
CY2020Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	227000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	13000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	344000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6700000
CY2021Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3819000
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4317000
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2021Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	11000
CY2020Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	23000
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	24000
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	47000
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	6800000
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3994000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4887000
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1079000
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1797000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	371000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3068000
CY2021Q2	us-gaap	Interest Expense InterestExpense	359000
CY2020Q2	us-gaap	Interest Expense InterestExpense	371000
	us-gaap	Interest Expense InterestExpense	719000
	us-gaap	Interest Expense InterestExpense	743000
CY2021Q2	us-gaap	Investment Income Net InvestmentIncomeNet	2000
CY2020Q2	us-gaap	Investment Income Net InvestmentIncomeNet	525000
	us-gaap	Investment Income Net InvestmentIncomeNet	16000
	us-gaap	Investment Income Net InvestmentIncomeNet	499000
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-357000
CY2020Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	154000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-703000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-244000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17489000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17299000
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3875000
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	393000
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	393000
CY2020Q2	us-gaap	Restricted Cash RestrictedCash	393000
CY2021Q2	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	598000
CY2020Q4	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	597000
CY2020Q2	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	1040000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18480000
CY2021Q2	us-gaap	Short Term Investments ShortTermInvestments	0
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	11698000
CY2020Q2	us-gaap	Short Term Investments ShortTermInvestments	29942000
CY2021Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	18480000
CY2020Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	29987000
CY2020Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	35250000

Files In Submission

Name	View Source	Status
0000950170-21-000951-index-headers.html	Edgar Link	pending
0000950170-21-000951-index.html	Edgar Link	pending
0000950170-21-000951.txt	Edgar Link	pending
0000950170-21-000951-xbrl.zip	Edgar Link	pending
clxt-20210630.htm	Edgar Link	pending
clxt-20210630.xsd	Edgar Link	pending
clxt-20210630ex31_1.htm	Edgar Link	pending
clxt-20210630ex31_2.htm	Edgar Link	pending
clxt-20210630ex32.htm	Edgar Link	pending
clxt-20210630_cal.xml	Edgar Link	unprocessable
clxt-20210630_def.xml	Edgar Link	unprocessable
clxt-20210630_htm.xml	Edgar Link	completed
clxt-20210630_lab.xml	Edgar Link	unprocessable
clxt-20210630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
img90253576_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBUS
Cibus, Inc. Stock $cbus

2021 Q3 Form 10-Q Financial Statement

#000095017021000951 Filed on August 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBUS Cibus, Inc. Stock $cbus

2021 Q3 Form 10-Q Financial Statement

#000095017021000951 Filed on August 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBUS
Cibus, Inc. Stock $cbus